McKesson Corporation has reached an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032. Under the agreement, McKesson would remain a primary distributor to CVS Health’s retail, mail-order and specialty pharmacies, as well as its distribution centers.
The extension continues a strategic relationship that has spanned more than 25 years. McKesson also reaffirmed its fiscal year 2027 adjusted earnings per share guidance.
The companies are expected to finalize a definitive contract based on the agreement in principle.